TrueBlue Clinical Research

For Sponsors / CROs

Your Dedicated Research Partner

Our Capabilities

Recruitment:

Operations:

Technology:

Equipment:

Therapeutic Areas

Internal Medicine
Infectious Disease
Mental Health
Dermatology
Immunology
AllergyAsthma
Vaccine
Neurology
Devices
TrueBlue Clinical Research

Consistently delivering positive results over a variety of indications.

COVID-19 BOOSTER VACCINE STUDY

Enrollment Goal: 40
Actual Enrollment: 108
0%
Enrollment Rate: 270%
0%
Retention Rate 96%
0%
Enrollment Timeline:
12 Weeks

ACNE VULGARIS STUDY

(Single Site, 3 Locations)
Enrollment Goal: 570
Actual Enrollment: 575
0%
Enrollment Rate: 101%
0%
Retention Rate 90%
0%
Enrollment Timeline:
12 Weeks

COVID-19 TREATMENT STUDY

Enrollment Goal: 30
Actual Enrollment: 52
0%
Enrollment Rate: 173%
0%
Retention Rate 93%
0%
Enrollment Timeline:
16 Weeks

GLUCOSE MONITOR
DEVICE STUDY

Enrollment Goal: 207
Actual Enrollment: 207
0%
Enrollment Rate: 100%
0%
Retention Rate 100%
0%
Enrollment Timeline:
12 Weeks

TINEA PEDIS STUDY

Enrollment Goal: 25
Actual Enrollment: 31
0%
Enrollment Rate: 124%
0%
Retention Rate 97%
0%
Enrollment Timeline:
10 Weeks

PLAQUE PSORIASIS STUDY

(Pilot study / Rescue Site)
Enrollment Goal: 3
Actual Enrollment: 9
0%
Enrollment Rate: 300%
0%
Retention Rate 100%
0%
Enrollment Timeline:
2 Weeks

For more information on our services, please get in contact with:

Robert soares
Client & Feasibility Manager

Partnerships

VersaTrial